Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Designer proteins provide new information about the body's signal processes

29.01.2014
Proteins play a fundamental role in almost all biological processes. They consist of chains constructed of up to 20 different amino acids, and their composition, structure and function are controlled by the genetic code.

Brilliant minds at the Center for Biopharmaceuticals are now attempting to rewrite the core function of proteins by making alterations in their molecular backbone, for example. By combining biological and chemical methods, researchers are able to design semi-synthetic proteins with almost no regard to the limitations of nature:

"Proteins can be regulated to perform specific biochemical tasks. We have used a technology that allows us to make changes to the molecular backbone of the protein and have thus created 22 completely new designer proteins on the basis of recognised material. Using advanced chemical-biological methods, we made the minuscule changes to the backbone of one of the most frequently occurring protein domains – a kind of fixed, independent module that features in a range of proteins. We then examined how the designer proteins bind to other proteins in the body, which allowed us to analyse the role of the specific protein domain in the body's vital signal processes," relates Søren W. Pedersen, postdoc.

All the cells in the body communicate via receptor proteins that are located in the cell membrane. This activates proteins inside the cell, causing specific effects which, in turn, stimulate the body to execute a variety of functions.

"Our designer proteins show us precisely how and where a bond is formed. This provides unique molecular understanding of the protein domain and a number of key protein bonds in the organism. For example the designer proteins bind to a range of receptors in the body – receptor interactions that are important targets for pharmaceuticals intended to treat stroke, pain and depression. The new findings mean that in the long term, we will be able to design pharmaceuticals that bind more strongly and more accurately to specific sites in the organism."

The fundamental findings have just been published in the scientific journal Nature Communications.

From 'on/off switch' to 'advanced dimmer'

Pharmaceuticals generally function by binding to a specific receptor that is involved in a given illness process – thus halting the damaging effect. Unfortunately, this strategy often generates side effects as the process simultaneously shuts down a number of beneficial functions. In recent years, interest has therefore arisen in a different strategy in which the pharmaceutical does not affect the receptor directly, but alters the interactions that the receptor has with proteins inside the cell. In other words, instead of simply switching the function of the receptor on and off, the objective is now to control parts of the receptor's effects. It is here that designer proteins can come to play a key role:

"The capacity to manipulate proteins has led to important breakthroughs in biotechnology and biomedicine. Proteins can often target specific processes in the cells with a high degree of accuracy – and at the Center for Biopharmaceuticals we are combining chemical synthesis and biological processes to find out more about the molecular interactions that may be of significance to biological pharmaceuticals," explains Professor Kristian Strømgaard, head of the Center for Biopharmaceuticals at the University of Copenhagen.

Contact:

Professor Kristian Strømgaard
Phone: 35 33 61 14
Proteins are composed of amino acids linked together in chains. In all organisms – from bacteria to human beings – there are 20 different amino acids available as 'building blocks' for the proteins.

It has conventionally been possible to use one of two methods to manufacture human proteins in the laboratory. The first method is biological and involves using gene technology to introduce the gene into single-cell organisms such as bacteria and yeast, or into mammal cells. The alternative is to create a protein chemically, which involves linking the amino acids together one by one until the required peptide or protein has been formed.

Each technology has its advantages and drawbacks. The production of proteins in bacteria and yeast is relatively simple to escalate to industrial scale, but gene technology is limited to the use of the 20 amino acids for which the genes code. The chemical method is not limited to the 20 amino acids, but it is expensive and can only be used to make small proteins containing up to 50 amino acids. Most of the 20,000 proteins in the human body are much larger.

Researchers at the Center for Biopharmaceuticals are combining biology and chemistry to make semi-synthetic proteins. This approach entails making only a part of the protein in bacteria or yeast, while the remaining part is created using chemical synthesis. The two sections are then 'glued together' to form the final designer protein.

Kristian Strømgaard | EurekAlert!
Further information:
http://www.ku.dk

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>